Schizophrenia
-
AbbVie boasts that it will become the largest CNS company in the industry next year!
In the field of biopharmaceuticals, there is no eternal No. 1, only infinite possibilities
-
【Urgent Request】European and American biotech companies are interested in licensing drugs for PD, AD and other CNS diseases
If interested in this licensing opportunity, please contact DrugTimes BD Team at BD@drugtimes.cn
